|
End-of-day quote
Nasdaq Stockholm
|
||
| - SEK | - |
|
| 16-07-20 | Meda : Mylan gets EU approval for Meda purchase, subject to conditions | RE |
| 16-07-15 | Exclusive - Mylan to get EU green light for Swedish drugmaker deal: sources | RE |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 52 | - | |
Mårten Österlund
LAW | General Counsel | 69 | 2014-12-08 |
Rainer Weiss
CTO | Chief Tech/Sci/R&D Officer | 64 | 2004-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 53 | 2016-08-24 | |
| Director/Board Member | 58 | 2016-08-24 | |
| Chairman | 52 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.88% | +6.38% | +76.86% | +128.23% | 1,109B | |
| +1.07% | +3.80% | +51.03% | +61.48% | 644B | |
| +1.20% | +6.21% | +26.47% | +76.45% | 463B | |
| +1.02% | +5.77% | +43.09% | +47.70% | 371B | |
| +0.85% | +4.07% | +23.88% | +41.58% | 301B | |
| +1.26% | +6.81% | +1.59% | +14.67% | 256B | |
| +1.88% | +5.81% | +48.54% | +68.52% | 234B | |
| +1.59% | +2.09% | -15.52% | -52.29% | 205B | |
| +1.87% | +5.61% | +25.81% | +92.42% | 178B | |
| Average | +1.29% | +4.10% | +31.31% | +53.20% | 417.9B | |
| Weighted average by Cap. | +1.14% | +4.47% | +44.34% | +72.58% |
- Stock Market
- Stocks
- Stock
Select your edition
All financial news and data tailored to specific country editions
